Can targeting #Galectin–glycan interactions reshape disease treatment?
This review highlights galectins as biomarkers and drug targets and examines advances in galectin inhibitors, #Glycoengineering and targeted protein degradation. @univbordeaux.bsky.social

#STTT doi.org/10.1038/s413...